Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Application of Robotic Stereotactic Radiotherapy to Peripheral Stage I Non-small Cell Lung Cancer with Curative Intent
Clinical Oncology, 09/11/09
Brown WT et al. – In this small cohort of patients with stage I peripheral NSCLC, robotic stereotactic radiotherapy seems to be a safe and obviously superior alternative to conventionally fractionated radiotherapy, with results that may be approaching those obtained with lobectomy without the associated morbidity.
Related Articles
Hypofractionated Stereotactic Radiotherapy and Radiosurgery for the Treatment of Patients with Radioresistant Brain Metastases
Anticancer Research, 11/13/09
Relevance Score: 65%
Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment For Lung Cancer Patients
ScienceDaily, 11/03/09
Relevance Score: 65%
Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 11/05/09
Relevance Score: 64%
Combination Cancer Therapy Damages Brain Function
Ivanhoe, 10/08/09
Relevance Score: 64%
Stereotactic body radiation therapy for liver metastases
European Journal of Cancer, 10/01/09
Relevance Score: 63%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation
European Journal of Cancer, 12/10/09
Stage I nonsmall cell lung cancer in patients aged >=75 years
Cancer, 12/10/09
Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma
Cancer Research, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


